Geode Capital Management
YDES

Geode Capital Management’s YD Bio Ltd YDES Stock Holding History

Geode Capital Management’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$464K Buy
60,236
+1,873
+3% +$18.1K ﹤0.01% 3610
2025
Q4 		$711K Buy
58,363
+5,292
+10% +$71.4K ﹤0.01% 3473
2025
Q3 		$1.03M Buy
+53,071
New +$923K ﹤0.01% 3372

Other funds holding YDES

Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management's YDES Position: Q1 2026 in Review

Geode Capital Management increased its YD Bio Ltd (YDES) stake by 3.2% in Q1 2026, buying an estimated $18.1K and bringing the position to 60,236 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #3610.

Geode Capital Management first reported a position in YDES in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.03M in Q3 2025. 8 funds tracked by Wall St. Rank hold YDES as of Q1 2026.

  • Geode Capital Management held 60,236 shares of YD Bio Ltd worth $464K as of Q1 2026.
  • Geode Capital Management bought 1,873 YD Bio Ltd shares in Q1 2026, an estimated $18.1K.
  • YD Bio Ltd made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3610 holding.
  • Geode Capital Management first reported a position in YD Bio Ltd in Q3 2025 and has held it in 3 quarters since.
  • Geode Capital Management's YD Bio Ltd position peaked at $1.03M in Q3 2025.
  • 8 funds tracked by Wall St. Rank held YD Bio Ltd as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.